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Report summary  
 
 
Since the birth of the cloned sheep Dolly a 
range of other mammalian species have been 
cloned using the traditional SCNT technology 
that was used when producing Dolly and using 
other methodologies. The success rates remain 
low (less than 5%) no matter what kind of 
methodology. However, the so-called Hand-
made Cloning approach where the methodology 
enables the nuclei transfer to be performed at a 
lower cost (both in equipment and trained 
persons) seems to have some advantages, main-
ly that it makes cloning cheaper per produced 
animal. 
 
The reasons to the low success rates have not 
been fully understood yet, but it seems that both 
methodological choices (donor cell lines, cell 
nutrition, maturation period of egg cell, level of 
technical skill etc) and other so-called epi-
genetic factors that are connected to the way 
that the cloned embryo reacts to the reprogram-
ming and the in vitro phase are involved. 
 
The problems associated with animal cloning 
show themselves from the first stages of the 
development of the cloned egg and until after 
the birth of the animals. Problems frequently 
occurring are: 
 
• Placental abnormalities  
• Fetal overgrowth, prolonged gestation  
• Stillbirth, hypoxia, respiratory failure and 
circulatory problems, lack of post-natal 
vigour 
• Increased body temperature at birth 
• Malformations in the urogenital tract 
(hydronephrosis, testicular hypoplasia) 
• Malformations in liver and brain 
• Immune dysfunction, lymphoid hypoplasia, 
anaemia, thymic atrophy  
• Bacterial and viral infections     
According to some recent information, con-
siderable success in partial or almost total elim-
ination of these developmental problems has 
been achieved in several laboratories by per-
forming slight modifications in the technique. 
Another positive sign is that offspring of the 
cloned animals do not show any increase in 
developmental problems compared to control 
animals, thus confirming the epigenetic and 
transient nature of the cloning-related syn-
dromes, and also widening the possibilities of 
practical application.  
 
Even so, the low success rates are the most 
important technical factor hampering the 
economic feasibility of a range of applications 
of farm animal cloning that can be found in the 
literature. These include: 
 
• Basic research: Using the cloning techno-
logy to gain a deeper insight into the ferti-
lization process and the development of the 
early foetus. 
• Disease models: Used together with genetic 
modification cloning can produce animals 
that mimic human diseases and thus perhaps 
lead to a better understanding of these and 
provide tailored animals that can be used to 
test new drugs on. 
• Bioreactors: Used together with genetic 
modification cloning can be used to produce 
animals that can be used as biological fac-
tories that express human proteins that can 
be harvested and used as medicine. 
• Agricultural applications: Used alone or 
together with genetic modification cloning 
can perhaps be used to produce animals that 
will increase productivity, animal welfare or 
the quality of food products. 
• Pets, endangered species, etc.: Cloning 
can be used for a range of more exotic pur-
poses, e.g. cloning pet cats or cloning indi-
2 
viduals from endangered species to increase 
the breeding populations. 
 
It is debated whether the technology can actual-
ly be used for all these purposes, since not only 
the low success rates but also the fact that clo-
ning does not produce genetically identical 
individuals and that two almost genetically 
identical individuals might differ strongly on 
the phenotypic level. This pertains especially to 
the agricultural applications where high success 
rates, public acceptance and the production of 
individual animals with specific desirable traits 
are necessary to make cloning economically 
feasible. 
 
The future of animal cloning is thus not clear, It 
can be regarded as a technology that has a lot of 
theoretical applications but according to the 
present efficiency it must be foreseen that in the 
near future it will mostly play a role within 
basic research and biomedicine where the value 
of each animal is very high. Whether the 
technology will become interesting from an 
agricultural point of view remains to be seen. 
There is no consensus on this subject among 
scientists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This report seeks to evaluate the state of the 
art of farm animal cloning based on a 
literature review with additional information 
gathered at a workshop held in Seville may 
2005, co-organised by the Institute of 
Prospective Technological Studies (European 
Commission: DG JRC-IPTS, Sustainability in 
Agriculture, Food and Health unit), the Danish 
Centre for Bioethics and Risk Assessment 
(CeBRA), and the European Commission DG 
RTD (Bio-technology, Agriculture and Food 
directorate) as part of the project CLONING 
IN PUBLIC. 
 
